← FDA Drug Approvals (Drugs@FDA)

IBRANCE

NDA · New Drug Application · Sponsor: PFIZER · Approved 2019-11-01

Drug application

FDA Application #

NDA212436

Application type

New Drug Application

Brand name

IBRANCE

Generic name

PALBOCICLIB

Active ingredients

PALBOCICLIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

PFIZER

Manufacturer

U.S. Pharmaceuticals

First approval

2019-11-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown